Prolyl hydroxylation regulates intracellular procollagen degradation in cultured rat cardiac fibroblasts

https://doi.org/10.1016/S0022-2828(95)90095-0Get rights and content

To determine the regulatory role of prolyl hydroxylation in intracellular cardiac procollagen turnover, we examined the effects of prolyl 4-hydroxylase inhibitors (α,α′-dipyridil, 3,4-dihydroxybenzoic acid ethyl ester, pyridine 2,4-dicarboxylic acid ethyl ester) and ascorbic acid on procollagen metabolism by cultured, neonatal rat cardiac fibroblasts. Ascorbate-deficient fibroblasts showed decreased rates of prolyl hydroxylation and total collagen accumulation without a significant reduction in α1(I) and α1(III) mRNA levels. The fraction of newly synthesized procollagens degraded intracellularly was also substantially increased in ascorbate-deficient cells (50±7 v 30±3% in ascorbate-deficient v control fibroblasts; P<0.05). These findings were associated with increased intracellular accumulation of Type I procollagen, enhanced secretion of “underhydroxylated” proα1(I) polypeptide into the cell culture medium, and decreased extracellular Type I collagen deposition. Similar results were obtained by treating cells with α,α′-dipyridil (300 μm), and 3,4-dihydroxybenzoic acid ethyl ester (400 μm) in the presence of ascorbate. A major portion of the enhanced degradation of newly synthesized procollagens occurred within acidic intracellular compartments as indicated by the inhibition of procollagen degradation by chloroquine (25 μm). Inhibition of procollagen secretion by colchicine (0.5 μg/ml) enhanced the diversion to, and subsequent intracellular degradation of underhydroxylated procollagens in cardiac fibroblast lysosomes. We conclude that inactivation of prolyl 4-hydroxylase increases intracellular accumulation and intralysosomal degradation of newly synthesized cardiac procollagen polypeptides. These observations suggest that procollagen prolyl hydroxylation may be important in the regulation of collagen accumulation by cardiac interstitial cells during fibrotic processes in vivo.

References (47)

  • TanzawaK et al.

    Type I procollagen N-proteinase from whole chick embryos

  • BergRA et al.

    Regulation of the production of secretory proteins: intracellular degradation of newly synthesized “defective” collagen

  • BhambiB et al.

    Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment

    Am J Pathol

    (1991)
  • BienkowskiRS

    Intracellular degradation of newly synthesized secretory proteins

    Biochem J

    (1983)
  • BingOHL et al.

    Mechanical properties of rat cardiac muscle during experimental hypertrophy

    Circ Res

    (1971)
  • BonninCM et al.

    Collagen synthesis and content in right ventricular hypertrophy in the dog

    Am J Physiol

    (1981)
  • CarverW et al.

    Collagen expression in mechanically stimulated cardiac fibroblasts

    Circ Res

    (1991)
  • ChapmanD et al.

    Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium

    Circ Res

    (1990)
  • ChuML et al.

    Cloning and characterization of five overlapping cDNAs specific for the human proα1(I) collagen chain

    Nucleic Acid Res

    (1982)
  • ChuaCC et al.

    Effect of growth factors on collagen metabolism in cultured human heart fibroblasts

    Conn Tis Res

    (1991)
  • EfimovskyO et al.

    Recherches sur l'acide methyl-2 pyridine-carboxylique-4

    Bull Soc Chem Fr

    (1954)
  • EghbaliM et al.

    Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression

    Mol Cell Biochem

    (1990)
  • EghbaliM et al.

    Differential effects of transforming growth factor-β1 and phorbol myristate acetate on cardiac fibroblasts

    Circ Res

    (1991)
  • Cited by (0)

    View full text